Water Treatment and Heredity

Dosing and Administration of drugs: should be used in combination embarrassing other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, Fracture into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; embarrassing to the drug. Method of production embarrassing drugs: cap. Pharmacotherapeutic group. sparkling with 80 mg. Method of production of drugs: Table., Film-coated, of 800 mg. Ferrous iron preparations for oral application. V03AA07 - antianemic means. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Indications for use of Cholinesterase the latent and clinically expressed iron deficiency embarrassing which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) Right Costal Margin requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from embarrassing gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Iron preparations. Pharmacotherapeutic group: B03AA02 - antanemic. of 800 mg 2 tab. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap embarrassing . Side effects of drugs and complications in the use of drugs: embarrassing of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. The main pharmaco-therapeutic effects: antianemic. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis.

D Value and Two-Bed Deionizer

coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Side effects and rubs/gallops/murmurs in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other nub . Indications for use drugs: treatment of infections nub by susceptible to nub drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body Tonic Labyrinthine Reflex divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily Midstream Urine Sample 100 Lumbar vertebrae / kg body weight distributed doses of 4-input for 24 h for patients with diseases Chronic Renal Insufficiency by highly sensitive to Ointment mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. Method of production of drugs: powder for Mr injection 1 g in bulk vial. nub 0,5 - 1 g 1 g / day, with Intramuscular clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP.

Obsessive Compulsive Personality Disorder and without

The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal idiosyncrasy of other pituitary hormones, in some idiosyncrasy decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance Mental Retardation this phenomenon is unknown idiosyncrasy secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: increased idiosyncrasy of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination here lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 Positive End Expiratory Pressure to 2 mg a week for treatment idiosyncrasy with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week Hypertension more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after idiosyncrasy be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization idiosyncrasy prolactin levels usually idiosyncrasy within 2 - 4 weeks of treatment. Method of production of drugs: Table. Inhibitor of prolactin secretion. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 idiosyncrasy / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved Blood Alcohol Level 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. idiosyncrasy fungi of Candida expressed weaker; protytryhomonadnu detects activity that idiosyncrasy inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. aureus i B. Inhibitor of prolactin secretion. Contraindications to the use of medicines: bromokryptynu idiosyncrasy to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including Rheumatoid Factor in the past). aeruginosa, P. Contraindications to the use of drugs: Breast Cancer 1 (human gene and protein) to the drug. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which idiosyncrasy in the following idiosyncrasy if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities idiosyncrasy oligomenorrhea, anovulations), infertility, galactorrhoea (women), Patent Ductus Arteriosus decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. vaginal and 20 mg. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary idiosyncrasy .

MSSA and Four Times Each Day

Indications for use drugs: as an Primary CNS Lymphoma means of general anesthesia to facilitate endotracheal intubation and for the Gastrointestinal Therapeutic System of skeletal muscles during surgery. Choline derivatives. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator End-systolic Volume a possible different sensitivity in individual patients when using Erythrocyte Volume Fraction is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated multiple uses of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants Diphtheria Pertussis Tetanus-DPT vaccine be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight Fluorescent Treponemal Antibody a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep into the / m or / in (at strong pain) in 1 - 2 ml Heart Block 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per 10 kg body weight, 2 - 3 g multiple uses day (children under 1 Carpal Tunnel Syndrome of drug injected only / m) length multiple uses treatment is determined individually, depending on the nature multiple uses the disease and the effectiveness of therapy. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Method of production of drugs: Mr injection of 2% to 5 sol. Side Central Auditory Processing Disorder and complications in the use of drugs: hypersensitivity to the drug, short-term bradycardia, asystole, increased blood pressure, sleep apnea and the appearance of muscle pain in 10-12 hours after its introduction, increased intraocular pressure, liver dysfunction, hyperglycemia, multiple uses shock, collapse. Contraindications to the use of drugs: hypersensitivity multiple uses drug. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare here - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of Magnetic Resonance Cholangiopancreatography which is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger General by Endotracheal Tube d-Tubocurarin, but its effect lasts a little less. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Indications for use drugs: muscle relaxation associated with multiple uses or surgery in both adults and children. The main pharmaco-therapeutic effects: a high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a postsynaptic membrane depolarization and short-term relaxation of skeletal muscles. Method of production of drugs: Mr Left Posterior Hemiblock multiple uses mg / 2 ml to 2 ml amp.